1. Home
  2. DRH vs BHVN Comparison

DRH vs BHVN Comparison

Compare DRH & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diamondrock Hospitality Company

DRH

Diamondrock Hospitality Company

N/A

Current Price

$12.32

Market Cap

2.5B

Sector

Real Estate

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$13.35

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DRH
BHVN
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
DRH
BHVN
Price
$12.32
$13.35
Analyst Decision
Buy
Buy
Analyst Count
10
14
Target Price
$10.38
$29.08
AVG Volume (30 Days)
2.3M
3.4M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
3.51%
N/A
EPS Growth
144.44
26.08
EPS
0.51
N/A
Revenue
$1,120,491,000.00
N/A
Revenue This Year
$3.44
N/A
Revenue Next Year
$2.42
N/A
P/E Ratio
$24.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.48
$7.48
52 Week High
$13.79
$18.57

Technical Indicators

Market Signals
Indicator
DRH
BHVN
Relative Strength Index (RSI) 49.74 36.40
Support Level $11.80 $8.75
Resistance Level $12.54 $13.54
Average True Range (ATR) 0.29 0.99
MACD 0.01 -0.39
Stochastic Oscillator 55.98 6.09

Price Performance

Historical Comparison
DRH
BHVN

About DRH Diamondrock Hospitality Company

Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The company operates in one reportable segment: The hotel ownership segment, which is comprised of upper upscale and luxury chain scale hotels that offer hotel rooms, food and beverage and other ancillary guest services.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: